Ran Li
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Epidemiology top 0.5%
- Autophagy in Disease and Therapy
Papers in
-
- RNA modifications and cancer 17
- RNA Research and Splicing 11
- Epigenetics and DNA Methylation 8
- Inflammasome and immune disorders 8
-
- Cancer-related molecular mechanisms research 25
- MicroRNA in disease regulation 16
- Co-authors
- Junling Gao (9 shared papers)Yanxia Tian (7 shared papers)Richard C. Wang (4 shared papers)Feng Jin (2 shared papers)Ying Cui (2 shared papers)Xiaohua Jiang (2 shared papers)Pei Jiang (2 shared papers)Changmeng Cui (1 shared paper)
- Journals
- Scientific Reports (6 papers)PLoS ONE (5 papers)Medicine (5 papers)Cell Death and Disease (5 papers)International Journal of Molecular Sciences (5 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Ran Li
305 papers receiving 9.2k citations
Ran Li's Hit Papers
Peers
Comparison fields: 5 of 182
- Cancer Research 1.0k
- Epidemiology 2.2k
- Biological Psychiatry 154
- Neurology 492
- Physiology 284
Countries citing papers authored by Ran Li
This map shows the geographic impact of Ran Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Li more than expected).
Fields of papers citing papers by Ran Li
This network shows the impact of papers produced by Ran Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Li. The network helps show where Ran Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Ran Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 319 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Induction of the Vitamin D Receptor Attenuates Autophagy Dysfunction-Mediated Cell Death Following Traumatic Brain Injury. Hit paper breakdown → | 2017 | 3372 |
| 2 | Amyloid β-based therapy for Alzheimer’s disease: challenges, successes and future Hit paper breakdown → | 2023 | 557 |
| 3 | 2016 | 133 | |
| 4 | 2012 | 126 | |
| 5 | Face-on oriented self-assembled molecules with enhanced π–π stacking for highly efficient inverted perovskite solar cells on rough FTO substrates Hit paper breakdown → | 2025 | 112 |
| 6 | 2018 | 108 | |
| 7 | 2022 | 105 | |
| 8 | 2014 | 92 | |
| 9 | 2022 | 89 | |
| 10 | 2016 | 87 | |
| 11 | 2014 | 86 | |
| 12 | 2009 | 82 | |
| 13 | 2011 | 82 | |
| 14 | 2021 | 82 | |
| 15 | 2016 | 80 | |
| 16 | 2016 | 79 | |
| 17 | 2015 | 78 | |
| 18 | 2017 | 74 | |
| 19 | 2020 | 71 | |
| 20 | 2016 | 68 |
About Ran Li
Ran Li is a scholar working on Molecular Biology, Cancer Research, Immunology, Pulmonary and Respiratory Medicine and Oncology, having authored 319 papers that have together received 9.3k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (25 papers), RNA modifications and cancer (17 papers), MicroRNA in disease regulation (16 papers), Air Quality and Health Impacts (12 papers), RNA Research and Splicing (11 papers), Climate Change and Health Impacts (9 papers), Epigenetics and DNA Methylation (8 papers) and Inflammasome and immune disorders (8 papers). The work is most often cited by research in Cancer Research (1.0k citations), Epidemiology (2.2k citations), Biological Psychiatry (154 citations), Neurology (492 citations) and Physiology (284 citations). Ran Li has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Junling Gao, Yanxia Tian, Richard C. Wang, Feng Jin, Ying Cui, Xiaohua Jiang, Pei Jiang, Changmeng Cui, Weihong Song and Huaqiu Chen. Their work appears in journals such as Scientific Reports, PLoS ONE, Medicine, Cell Death and Disease and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.